- Home
- PMAX vs POAI Comparison
PMAX vs POAI Comparison
Compare PMAX & POAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMAX
- POAI
- Stock Information
- Founded
- PMAX 2019
- POAI 2002
- Country
- PMAX Hong Kong
- POAI United States
- Employees
- PMAX N/A
- POAI N/A
- Industry
- PMAX
- POAI Industrial Specialties
- Sector
- PMAX
- POAI Health Care
- Exchange
- PMAX Nasdaq
- POAI Nasdaq
- Market Cap
- PMAX 6.9M
- POAI 6.5M
- IPO Year
- PMAX 2024
- POAI N/A
- Fundamental
- Price
- PMAX $2.73
- POAI $9.47
- Analyst Decision
- PMAX
- POAI Hold
- Analyst Count
- PMAX 0
- POAI 1
- Target Price
- PMAX N/A
- POAI N/A
- AVG Volume (30 Days)
- PMAX 1.5M
- POAI 68.1K
- Earning Date
- PMAX 09-23-2025
- POAI 11-14-2025
- Dividend Yield
- PMAX N/A
- POAI N/A
- EPS Growth
- PMAX N/A
- POAI N/A
- EPS
- PMAX N/A
- POAI N/A
- Revenue
- PMAX $4,799,100.00
- POAI $1,664,696.00
- Revenue This Year
- PMAX N/A
- POAI $486.27
- Revenue Next Year
- PMAX N/A
- POAI $65.50
- P/E Ratio
- PMAX N/A
- POAI N/A
- Revenue Growth
- PMAX N/A
- POAI 71.65
- 52 Week Low
- PMAX $1.87
- POAI $8.01
- 52 Week High
- PMAX $30.56
- POAI $45.90
- Technical
- Relative Strength Index (RSI)
- PMAX 61.78
- POAI 52.42
- Support Level
- PMAX $2.52
- POAI $8.05
- Resistance Level
- PMAX $3.03
- POAI $9.84
- Average True Range (ATR)
- PMAX 0.46
- POAI 0.91
- MACD
- PMAX -0.08
- POAI -0.78
- Stochastic Oscillator
- PMAX 8.60
- POAI 24.86
About PMAX Powell Max Limited Class A Ordinary Shares
Powell Max Ltd is an financial communications services provider. Its financial communications services cover a full range of financial printing, corporate reporting, communications and language support services from inception to completion, including typesetting, proofreading, translation, design, printing, electronic reporting, newspaper placement and distribution. It operates in a single business segment which is the provision of corporate financial communications and financial printing services. All operations are carried in Hong Kong.
About POAI Predictive Oncology Inc.
Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.